Drug Shortage Report for HALOPERIDOL INJ 5MG/ML USP

Last updated on 2022-10-20 History
Report ID 171063
Drug Identification Number 00808652
Brand name HALOPERIDOL INJ 5MG/ML USP
Common or Proper name HALOPERIDOL
Company Name SANDOZ CANADA INCORPORATED
Market Status MARKETED
Active Ingredient(s) HALOPERIDOL
Strength(s) 5MG
Dosage form(s) LIQUID
Route of administration INTRAMUSCULAR INTRAMUSCULAR
Packaging size 1ML 10LIAM
ATC code N05AD
ATC description ANTIPSYCHOTICS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2022-10-04
Estimated end date 2022-10-21
Actual end date 2022-10-19
Shortage status Resolved
Updated date 2022-10-20
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 110 RUE DE LAUZON
BOUCHERVILLE, QUEBEC
CANADA J4B 1E6
Company contact information 1 800-361-3062

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v8 2022-10-20 English Compare
v7 2022-10-19 French Compare
v6 2022-10-19 English Compare
v5 2022-10-12 French Compare
v4 2022-10-12 English Compare
v3 2022-10-05 English Compare
v2 2022-10-04 French Compare
v1 2022-10-04 English Compare

Showing 1 to 8 of 8